Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-052592

Director sold 2,850 shares at $20.00 ($57,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
OLUKOTUN ADEOYE Y Director 2024-12-27 Sale 10b5-1 −2,850 $20.00 $57,000 36,740 D
Open-market sales · 2,850 sh · avg $20.00 · $57,000
Loading xslF345X05/wk-form4_1735596735.xml…